ask="2.0600"
ask_size="500"
average_daily_volume="472113"
bid="1.6500"
bid_size="10000"
book_value="0.1250"
change="+0.0724"
change_from_200_day_moving_average="0.5381"
change_from_50_day_moving_average="0.5903"
change_from_52_week_high="-1.2676"
change_From_52_week_low="1.2924"
change_in_percent="+4.2339%"
close="1.7824"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.8300"
ebitda="-21.56M"
eps_estimate_current_year="-0.8100"
eps_estimate_next_quarter="-0.1800"
eps_estimate_next_year="-0.8700"
ex_dividend_date="N/A"
float_shares="18812000"
high="1.8900"
high_52_weeks="3.0500"
last_trade_date="2/23/2017"
last_trade_price="1.7824"
last_trade_size="1500"
last_trade_time="3:58pm"
low="1.5700"
low_52_weeks="0.4900"
market_capitalization="52.40M"
moving_average_200_day="1.2443"
moving_average_50_day="1.1921"
name="Galectin Therapeutics Inc."
notes="N/A"
one_year_target_price="1.1200"
open="1.7100"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+43.2475%"
percent_change_from_50_day_moving_average="+49.5227%"
percent_change_from_52_week_high="-41.5607%"
percent_change_from_52_week_low="+263.7551%"
previous_close="1.7100"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="13.6800"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="29396000"
short_ratio="3.9600"
stock_exchange="NCM"
symbol="GALT"
volume="514408"
weeks_range_52="0.4900 - 3.0500"
